As Elon Musk's Neuralink completes its first successful human trial this January, brain-computer interface (BCI) technology faces a critical juncture. Can we ethically merge silicon with synapses while maintaining cognitive sovereignty? The global BCI market, projected to reach $6.2 billion by 2030 according to Grand View Research, struggles with a 43% abandonment rate in clinical trials due to signal fidelity issues.
Enter your inquiry details, We will reply you in 24 hours.
Brand promise worry-free after-sales service